Article
An APOC3 3'UTR variant associated with plasma triglycerides levels and coronary heart disease by creating a functional miR-4271 binding site.
Scientific reports - 14 Sept 2016
Hu Sen-Lin, Cui Guang-Lin, Huang Jin, Jiang Jian-Gang, Wang Dao-Wen
Abstract excerpt
Apolipoprotein C-III (APOC3) is a key regulator of plasma triglycerides levels. Increasing evidence has shown that loss-of-function mutations in APOC3 is associated with reduction in plasma triglycerides levels and will confer a benefit in patients at high risk for cardiovascular disease. However, these favorable mutations were extremely distribution discrepant among different ethnics. In this study, the APOC3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
